Source disclosure: February 05, 2026
ZERIA PHARMACEUTICAL CO.,LTD. [4559.T]
TOKYO, Feb 05 (Pulse News Wire) – Zeria Pharmaceutical CO.,LTD. (4559.T) announced today that its board of directors, held on February 05, 2026, resolved to cancel treasury shares based on Article 178 of the Companies Act.
According to the resolution, the company plans to cancel ordinary shares totaling 1,000,000 shares, which represents 1.96% of the outstanding shares prior to cancellation. The cancellation is scheduled to take place on February 25, 2026.
Following the cancellation, the total number of outstanding shares of the company will be reduced to 50,119,190 shares.
AI-translated content. 🟢 Confidence: High See terms • Original filing
💬 Help us improve translation quality
Notice any errors in this article? Let us know with one click.